$12.42
1.31% day before yesterday
Nasdaq, Jan 02, 10:04 pm CET
ISIN
US68401U2042
Symbol
OPRX

OptimizeRx Corporation Stock price

$12.42
-1.69 11.98% 1M
-0.70 5.34% 6M
+0.16 1.31% YTD
+7.21 138.39% 1Y
-4.38 26.07% 3Y
-20.94 62.77% 5Y
+8.70 233.87% 10Y
-687.58 98.23% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
+0.16 1.31%
ISIN
US68401U2042
Symbol
OPRX

Key metrics

Basic
Market capitalization
$231.5m
Enterprise Value
$240.1m
Net debt
$8.6m
Cash
$19.5m
Shares outstanding
18.6m
Valuation (TTM | estimate)
P/E
- | 16.3
P/S
2.1 | 2.1
EV/Sales
2.2 | 2.2
EV/FCF
20.8
P/B
1.9
Financial Health
Equity Ratio
68.4%
Return on Equity
-17.2%
ROCE
4.5%
ROIC
0.1%
Debt/Equity
0.2
Financials (TTM | estimate)
Revenue
$109.5m | $110.3m
EBITDA
$11.1m | $17.8m
EBIT
$6.8m | $5.7m
Net Income
$30.0k | $14.2m
Free Cash Flow
$11.6m
Growth (TTM | estimate)
Revenue
24.2% | 19.8%
EBITDA
245.3% | 1,044.1%
EBIT
156.9% | 191.5%
Net Income
100.1% | 170.6%
Free Cash Flow
1,133.0%
Margin (TTM | estimate)
Gross
65.3%
EBITDA
10.1% | 16.2%
EBIT
6.2%
Net
0.0% | 12.9%
Free Cash Flow
10.6%
More
EPS
$0.0
FCF per Share
$0.6
Short interest
9.6%
Employees
129
Rev per Employee
$710.0k
Show more

Is OptimizeRx Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

OptimizeRx Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a OptimizeRx Corporation forecast:

11x Buy
85%
2x Hold
15%

Analyst Opinions

13 Analysts have issued a OptimizeRx Corporation forecast:

Buy
85%
Hold
15%

Financial data from OptimizeRx Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
110 110
24% 24%
100%
- Direct Costs 38 38
14% 14%
34%
72 72
30% 30%
65%
- Selling and Administrative Expenses 60 60
3% 3%
55%
- Research and Development Expense - -
-
-
11 11
245% 245%
10%
- Depreciation and Amortization 4.34 4.34
2% 2%
4%
EBIT (Operating Income) EBIT 6.76 6.76
157% 157%
6%
Net Profit 0.03 0.03
100% 100%
0%

In millions USD.

Don't miss a Thing! We will send you all news about OptimizeRx Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

OptimizeRx Corporation Stock News

Positive
Seeking Alpha
11 days ago
OptimizeRx's Q3 2025 results reinforce my long-term bullish thesis. OPRX demonstrates continued operational momentum, supporting confidence in sustained growth. Recent earnings solidify conviction in the company's strategic positioning and execution.
Neutral
GlobeNewsWire
18 days ago
WALTHAM, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced four new partner agreements that meaningfully expand the Company's in-workflow point-of-care (POC) network, fortify its long-term com...
Neutral
Seeking Alpha
about 2 months ago
OptimizeRx Corporation ( OPRX ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Stephen Silvestro - President & CEO Edward Stelmakh - Chief Financial & Strategic Officer Andrew D'Silva - Chief Business Officer Conference Call Participants Ryan Daniels - William Blair & Company L.L.C., Research Division Richard Baldry - ROTH Capital Partners, LLC, Research Division David ...
More OptimizeRx Corporation News

Company Profile

OptimizeRx Corp. engages in the provision of digital health messaging via electronic health records, which serves as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers EHR workflow solutions which include financial messaging, patient education, and brand messaging; and brand support. The company was founded by David A. Harrell on November 8, 1985 and is headquartered in Rochester, MI.

Head office United States
CEO Stephen Silvestro
Employees 129
Founded 1985
Website www.optimizerx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today